Jennifer Birkmose

Jennifer Cain Birkmose is the Vice President and Global Head of Patient Access and Community Engagement at Swedish Orphan Biovitrum (SOBI). Jennifer is also a member of the Executive Board of Medicine’s for Malaria Venture (MMV), a public private development partnership to develop and launch Malaria medicines.

Prior to joining Sobi, Jennifer lead Market Access for Region Europe for Roche, Market Access for Emerging Markets for Novartis, and Market Access for EMEA in Janssen.

Prior to joining the Pharmaceutical industry, Jennifer worked in Copenhagen and Brussels for the European Regional Office of The World Health Organization (WHO) in the European Observatory of Health Systems. Jennifer has also worked in Washington, DC for PAHO and the World Bank.

Jennifer is a Visiting Lecturer at INSEAD Business School in France, a visiting Lecturer at the London School of Economics and is the founder and Ambassador for Singularity University, Basel.

Skills

• Statistics
  
• Competitive Intelligence
  
• Immunology
  

Education

• MBA Solvay Business School (2002.09 — 2004.06)
• MPH The Johns Hopkins University (1998 — 2000)
• BS Willamette University (1989.09 — 1993.05)
• Georgetown University
• High School Degree Sherwood